Loading chat...
NJ S2035
Bill
Status
Introduced
3/16/2020
Primary Sponsor
Troy Singleton
Click for details
AI Summary
Legislative Description
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.
Substituted by another Bill
Last Action
Substituted by A277 (1R)
6/3/2021
Committee Referrals
Health, Human Services and Senior Citizens3/16/2020
Full Bill Text
No bill text available